Kaleido Biosciences’ $35.6 Million Common Stock Offering

Latham & Watkins LLP represented the underwriters in the offering. Kaleido Biosciences was represented by Goodwin Procter LLP.

Kaleido Biosciences has closed an underwritten public offering of 4,750,000 shares of its common stock at a public offering price of $7.50 per share. In addition, Kaleido has granted the underwriters a 30-day option to purchase up to an additional 712,500 shares of its common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds to Kaleido from this offering were approximately $35.6 million.

Morgan Stanley & Co. LLC and Canaccord Genuity LLC acted as underwriters for the offering.

Kaleido Biosciences, Inc. is a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health.

Latham & Watkins represented the underwriters with a capital markets team led by partners Peter Handrinos (Picture) and Wesley Holmes, with associates Samuel Niles and Emily Henderson. Advice was also provided on regulatory matters by partner Ben Haas, with associate Barrett Tenbarge; on intellectual property matters by partner Alan Tamarelli, with associate Jiqiang Lin; and on tax matters by partner Jocelyn Noll, with associate Joseph Curran.

The Goodwin team was led by Kingsley Taft, Laurie Burlingame, Carly Ward, Kim Larie, and Kristina Jacobs, and included Dan Karelitz, Ettore Santucci, and Nathan Needle.
Involved fees earner: Laurie Burlingame – Goodwin Procter; Kristina Jacobs – Goodwin Procter; Daniel Karelitz – Goodwin Procter; Kimberly Larie – Goodwin Procter; Ettore Santucci – Goodwin Procter; Kingsley Taft – Goodwin Procter; Carolyn Ward – Goodwin Procter; Joseph Curran – Latham & Watkins; Ben Haas – Latham & Watkins; Peter Handrinos – Latham & Watkins; Emily Henderson – Latham & Watkins; Wesley Holmes – Latham & Watkins; Jiqiang Lin – Latham & Watkins; Samuel Niles – Latham & Watkins; Jocelyn Noll – Latham & Watkins; Alan Tamarelli Jr. – Latham & Watkins; Barrett Tenbarge – Latham & Watkins;

Law Firms: Goodwin Procter; Latham & Watkins;

Clients: Canaccord Genuity; Kaleido Biosciences; Morgan Stanley;


Author: Ambrogio Visconti